A, S., K, H., N, P., S, E., TM, H., & NK, N. (2023). Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization. Breast cancer research and treatment, 198(1), 143. https://doi.org/10.1007/s10549-023-06860-z
Chicago Style (17th ed.) CitationA, Shanmugalingam, Hitos K, Pathmanathan N, Edirimmane S, Hughes TM, and Ngui NK. "Comparison of Breast Cancer HER-2 Receptor Testing with Immunohistochemistry and in Situ Hybridization." Breast Cancer Research and Treatment 198, no. 1 (2023): 143. https://doi.org/10.1007/s10549-023-06860-z.
MLA (9th ed.) CitationA, Shanmugalingam, et al. "Comparison of Breast Cancer HER-2 Receptor Testing with Immunohistochemistry and in Situ Hybridization." Breast Cancer Research and Treatment, vol. 198, no. 1, 2023, p. 143, https://doi.org/10.1007/s10549-023-06860-z.